Insight Molecular Diagnostics Inc. (OCX)
NASDAQ
Closed
Aug 25, 2026
Day's Range
4.3552 wk Range
2.33Overview - OCX - Insight Molecular Diagnostics Inc.
Key Statistics
Valuation
Enterprise Value
72.51M
P/E (Trailing)
‪-0.95‬
P/E (Forward)
‪-1.84‬
PEG Ratio
‪0.05‬
Price / Sales (TTM)
‪41.19‬
Price / Book
‪129.49‬
EV / EBITDA
‪-3.41‬
Profitability
Gross Margin
‪67.56%‬
Profit Margin
‪39.34%‬
Operating Margin
‪-3,220.57%‬
Return on Assets
‪-173.67%‬
Return on Equity
‪496.38%‬
Ownership
Shares Outstanding
28.59M
Analyst Consensus
4 analysts
Market Cap - OCX - Insight Molecular Diagnostics Inc.
Peers - OCX - Insight Molecular Diagnostics Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- OCXNASDAQInsight Molecular Diagnostics Inc.75.74MMarket Cap+42.63%52-week change-0.93P/E (Trailing)‪39.34%‬Profit Margin
- NTRANASDAQNATERA INC (Common Stock) – ticker 45E47.23BMarket Cap+50.52%52-week change-220.14P/E (Trailing)‪-7.10%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.44.07BMarket Cap-14.69%52-week change39.06P/E (Trailing)‪25.03%‬Profit Margin
- ILMNNASDAQIllumina, Inc.33.70BMarket Cap+55.77%52-week change41.01P/E (Trailing)‪18.33%‬Profit Margin
- GHNASDAQGuardant Health Inc.22.13BMarket Cap+61.54%52-week change-49.67P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings Inc.17.13BMarket Cap+23.58%52-week change36.41P/E (Trailing)‪17.66%‬Profit Margin
- ICICLRNASDAQICON plc13.38BMarket Cap-0.84%52-week change264.97P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - OCX - Insight Molecular Diagnostics Inc.
About
Insight Molecular Diagnostics Inc. is a precision diagnostics company specializing in the development and commercialization of advanced molecular diagnostic tests for both clinical and research applications. With a core focus on transplant medicine and oncology, the company’s product portfolio includes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
